PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
21625451 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
large registries of potential unrelated stem cell donors have been established in order to enable stem cell transplantation for patients without hla-identical related donors. | |||||||
21681924 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | negative | |
the present study evaluated the feasibility and efficacy of reduced-intensity allogeneic stem cell transplantation (ri allosct) in six children with nb who failed tandem hdct/autosct.procedurea cyclophosphamide/fludarabine regimen was used as a conditioning for hla-matched sct, and atg was added for haploidentical sct. | |||||||
21712058 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | Chinese | NA | NA | unclassified | |
human leukocyte antigen (hla), which is extremely polymorphic, plays an important role in stem cell transplantation. | |||||||
21784536 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | cyclophosphamide | NA | methotrexate | NA | unclassified | |
NA | |||||||
21872626 | HLA-B*44 | stem cell transplantation | NA | NA | NA | unclassified | |
to validate that hla-b*44:02:01:01 and -b*44:27 represent functionally identical alleles that might reflect a permissive mismatch in hematopoetic stem cell transplantation (hsct), we determined their peptide-binding features. | |||||||
21872626 | HLA-B*44 | stem cell transplantation | NA | NA | NA | unclassified | |
to validate that hla-b*44:02:01:01 and -b*44:27 represent functionally identical alleles that might reflect a permissive mismatch in hematopoetic stem cell transplantation (hsct), we determined their peptide-binding features. | |||||||
21925086 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
for many years, a central aim has been the development of stem cell transplantation across the hla barrier and the use of haploidentical parents as stem cell donors. | |||||||
21925099 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
immunoselection and clinical use of t regulatory cells in hla-haploidentical stem cell transplantation. | |||||||
21970832 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
purpose of reviewhaematopoietic stem cell transplantation (hsct) is the mainstay of definitive treatment for children with a wide spectrum of primary immunodeficiencies (pids), but outcome is heavily dependent on the availability of a human leukocyte antigen-matched donor. | |||||||
22057509 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | doxorubicin | NA | prednisolone | NA | unclassified | |
NA |
Copyright 2024